comparemela.com

Latest Breaking News On - Acasti pharma inc stock exchange - Page 1 : comparemela.com

ACASTI PHARMA INC : Change in Directors or Principal Officers, Other Events (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 8, 2023, the Company appointed Dr.. | May 11, 2023

Acasti Successfully Submits Pivotal GTX-104 Phase 3 Safety Study Protocol with FDA and Implements Strategic Realignment Plan That Extends Projected Cash Runway Through Calendar Q2 2025

Company successfully submits GTX-104 Pivotal Phase 3 protocol IND amendment to the FDA with expectation for first patient dosed in calendar Q4 2023 Strategic realignment prioritizes GTX-104 and. | May 8, 2023

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.